212 related articles for article (PubMed ID: 23541441)
1. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment.
Hartwig FP; Collares T
Ageing Res Rev; 2013 Mar; 12(2):642-52. PubMed ID: 23541441
[TBL] [Abstract][Full Text] [Related]
2. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in dyskeratosis congenita.
Nishio N; Kojima S
Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
Agarwal S
Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
[TBL] [Abstract][Full Text] [Related]
5. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
[TBL] [Abstract][Full Text] [Related]
6. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
7. Dyskeratosis congenita.
Bessler M; Wilson DB; Mason PJ
FEBS Lett; 2010 Sep; 584(17):3831-8. PubMed ID: 20493861
[TBL] [Abstract][Full Text] [Related]
8. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
9. [Dyskeratosis congenita, a disease caused by defective telomere maintenance].
Hoareau-Aveilla C; Henry Y; Leblanc T
Med Sci (Paris); 2008 Apr; 24(4):390-8. PubMed ID: 18405638
[TBL] [Abstract][Full Text] [Related]
10. Dyskeratosis congenita associated with leukoplakia of the tongue.
Noto Z; Tomihara K; Furukawa K; Noguchi M
Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
[TBL] [Abstract][Full Text] [Related]
11. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
Mason PJ; Wilson DB; Bessler M
Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
[TBL] [Abstract][Full Text] [Related]
12. [Dyskeratosis congenita: short telomeres are not the rule].
Touzot F; Le Guen T; de Villartay JP; Revy P
Med Sci (Paris); 2012; 28(6-7):618-24. PubMed ID: 22805138
[TBL] [Abstract][Full Text] [Related]
13. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Ballew BJ; Savage SA
Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
[TBL] [Abstract][Full Text] [Related]
14. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
Vulliamy TJ; Knight SW; Mason PJ; Dokal I
Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow failure and the new telomere diseases: practice and research.
Young NS
Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
[TBL] [Abstract][Full Text] [Related]
16. Dyskeratosis congenita as a disorder of telomere maintenance.
Nelson ND; Bertuch AA
Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
[TBL] [Abstract][Full Text] [Related]
17. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis and therapeutic measures in patients with dyskeratosis congenita].
Reiger Z; Varga G; Tóth B; Maródi L; Erdos M
Orv Hetil; 2010 Feb; 151(8):285-92. PubMed ID: 20153999
[TBL] [Abstract][Full Text] [Related]
19. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability.
Le Guen T; Jullien L; Touzot F; Schertzer M; Gaillard L; Perderiset M; Carpentier W; Nitschke P; Picard C; Couillault G; Soulier J; Fischer A; Callebaut I; Jabado N; Londono-Vallejo A; de Villartay JP; Revy P
Hum Mol Genet; 2013 Aug; 22(16):3239-49. PubMed ID: 23591994
[TBL] [Abstract][Full Text] [Related]
20. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
Pereboeva L; Hubbard M; Goldman FD; Westin ER
PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
